Kidney injury is a significant complication in end-stage liver disease (ESLD), leading to increased morbidity and mortality. While liver transplant alone (LTA) can promote kidney recovery (KR), non-recovery associates with adverse outcomes, but the underlying pathophysiology is still unclear. We studied 10 LTA recipients with or without kidney failure (KF) and measured serum levels of OPN and TIMP-1 (previously identified predictors of KR), 92 proinflammatory proteins (Olink), and urinary cell populations. Our findings revealed elevated OPN and TIMP-1 levels in KF patients, strongly correlated with tubular epithelial cells in urine. Proteomic analysis showed distinct profiles in KF, non-KF, and healthy donors, indicating an ongoing proinflammatory signature in KF. Cytokines correlated with OPN and TIMP-1 levels. We propose that high pre-LTA OPN and TIMP-1 levels are crucial for tubular regeneration and normalize with kidney recovery. Insufficient pre-LTA OPN levels may lead to persistent kidney failure. Our present data also newly indicate that kidney failure post-LTA is an active condition, in which tubular cells are persistently shed in the urine. The strict association between systemic inflammation and tubular cell loss suggests a pathogenic link that could offer therapeutic opportunities to promote kidney recovery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11493771PMC
http://dx.doi.org/10.3389/frtra.2024.1480383DOI Listing

Publication Analysis

Top Keywords

opn timp-1
16
kidney recovery
12
kidney failure
12
timp-1 levels
12
kidney
8
inflammation tubular
8
promote kidney
8
pre-lta opn
8
tubular
5
levels
5

Similar Publications

Kidney injury is a significant complication in end-stage liver disease (ESLD), leading to increased morbidity and mortality. While liver transplant alone (LTA) can promote kidney recovery (KR), non-recovery associates with adverse outcomes, but the underlying pathophysiology is still unclear. We studied 10 LTA recipients with or without kidney failure (KF) and measured serum levels of OPN and TIMP-1 (previously identified predictors of KR), 92 proinflammatory proteins (Olink), and urinary cell populations.

View Article and Find Full Text PDF

Background: Dilated cardiomyopathy (DCM) involves myocardial remodeling, characterized by significant fibrosis and extracellular matrix expansion. These changes impair heart function, increasing the risk of heart failure and sudden cardiac death. This study investigates the prognostic value of circulating fibrosis biomarkers as a less invasive method in DCM patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates a genetic variant (p.Arg90His) in the neutrophil cytosolic factor 1 gene related to systemic lupus erythematosus and its association with systemic sclerosis (SSc).
  • Data from diverse cohorts indicate that the -H90 allele significantly increases the risk of developing diffuse cutaneous SSc and lung fibrosis in affected patients.
  • Findings reveal that this variant enhances profibrotic responses in blood monocytes and macrophages, contributing to the severity of lung fibrosis, both in mouse models and human patients with SSc.
View Article and Find Full Text PDF

Is renal dysfunction amplified in an arginine vasopressin induced rat model of preeclampsia?

Reprod Biol

September 2024

Department of Basic Medical Sciences, Faculty of Health Sciences, Durban University of Technology, Durban, South Africa. Electronic address:

Article Synopsis
  • The study examines the role of renal dysfunction in the pathophysiology of preeclampsia using an arginine vasopressin (AVP) rat model, which had not been thoroughly investigated before.
  • Female Sprague Dawley rats were infused with AVP or saline for 18 days, and urine samples were analyzed for various kidney injury biomarkers.
  • Findings revealed significant elevations of markers like albumin and NGAL/lipocalin-2 in the AVP group, indicating kidney damage, and support the model's utility in exploring renal damage mechanisms in preeclampsia.
View Article and Find Full Text PDF

Background: CALGB 90401 (Alliance) was a phase III trial of 1050 patients with metastatic castration-resistant prostate cancer (mCRPC) comparing docetaxel, prednisone, bevacizumab (DP+B) versus DP alone. While this trial did not show an improvement in overall survival (OS), there were improved intermediate outcomes suggesting that subsets of men may derive benefit from this combination. The purpose of this analysis was to identify prognostic and predictive biomarkers associated with OS and progression-free survival (PFS) benefit from DP+B.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!